Sellas Life Sciences Group Inc
Change company Symbol lookup
Select an option...
SLS Sellas Life Sciences Group Inc
PFNX Pfenex Inc
BAC Bank of America Corp
DLTR Dollar Tree Inc
SOLCF SOL Global Investments Corp
MLTI Credit Suisse X-Links Multi-Asset High Income ETN
JPM-E JPMorgan Chase & Co
BSET Bassett Furniture Industries Inc
INDB Independent Bank Corp
CPHI China Pharma Holdings Inc
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system.

Closing Price
$1.46
Day's Change
-0.07 (-4.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.58
Day's Low
1.46
Volume
(Light)
Volume:
199,282

10-day average volume:
385,459
199,282
  • Prev Close
    1.53
  • Today's Open
    1.53
  • Day's Range
    1.46-1.58
  • Avg Vol (10-day)
    385.5K
  • Last (time)
    4:00p ET 01/18/19
  • Last (size)
    3
  • 52-Wk Range
    0.8001 - 11.09
    LowHigh
  • (04/03/18 - 08/20/18)
    82.48%
  • 147.7%
  • Market Cap
    32.2M
  • Shares Outstanding
    22.0M
  • -4.96
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.6
  • 29.46
  • (% of float 12/31/18)
    9.89

Latest News

January 08, 2019
8:40 am ET
Globe Newswire
December 06, 2018
8:30 am ET
Globe Newswire
November 30, 2018
8:30 am ET
Globe Newswire
November 28, 2018
8:30 am ET
Globe Newswire
November 26, 2018
8:30 am ET
Globe Newswire
November 15, 2018
7:45 am ET
Globe Newswire
November 09, 2018
8:55 am ET
Globe Newswire
8:30 am ET
Globe Newswire
November 08, 2018
8:45 am ET
Globe Newswire
November 02, 2018
9:31 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.